Related Experiment Video
Updated: May 5, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Pilot study to validate a computer-based clinical decision support system for dyslipidemia treatment (HTE-DLP)
A Zamora1, F Fernández de Bobadilla, C Carrion
1TransLab Research Group, Medical Sciences Department, University of Girona, Catalonia, Spain; Lipid and Atherosclerosis Unit, Hospital de Blanes, Girona, Spain; Heracles Cardiovascular Network, Spain; Department of Internal Medicine, Hospital de Blanes, Girona, Spain.
Insights
A pilot study found that a Computerized Decision Support System (CDSS) significantly improved hyperlipidemia treatment in high-risk cardiovascular patients, leading to better LDL-C reduction.
Area of Science:
- Cardiology
- Medical Informatics
- Pharmacology
Background:
- Hyperlipidemia management is crucial for reducing cardiovascular risk.
- Current treatment protocols require optimization for high-risk populations.
- Computerized Decision Support Systems (CDSS) offer potential for improving clinical decision-making.
Purpose of the Study:
- To validate a specific CDSS (HTE-DLP) for enhancing hyperlipidemia treatment.
- To assess the efficacy of HTE-DLP in achieving target LDL-C levels in high-risk patients.
Main Methods:
- A pilot study randomized 77 high-risk cardiovascular patients.
- 10 expert physicians utilized the HTE-DLP system, which provided automated lipid treatment reminders.
- The primary outcome was the proportion of patients achieving LDL-C <70 mg/dl after 12 weeks.
Main Results:
- The intervention group, using HTE-DLP, showed a significantly higher achievement of LDL-C <70 mg/dl (55.0% vs 12.5%, p=0.003).
- Increased use of high-potency statins and combination therapy was observed in the intervention group (p=0.001).
- Physicians reported high agreement (86.1%) and ease of use (85%) with the HTE-DLP system, with acceptable cost-effectiveness.
Conclusions:
- The implementation of a CDSS (HTE-DLP) led to a significant reduction in LDL-C levels among high-risk cardiovascular patients.
- HTE-DLP demonstrates potential as an effective tool for optimizing hyperlipidemia management and improving patient outcomes.
Unlabelled:
Pilot study to validate a Computerized Decision Support Systems (CDS) (HTE-DLP) for improving treatment of hyperlipidemia.
Methods:
HTE-DLP was programmed to offer automatic specific reminders for lipid treatment. Seventy-seven patients with high cardiovascular risk were randomized. 10 expert physicians in cardiovascular-risk management were recruited. We assessed number of patients at LDL <70 mg/dl after 12 weeks of treatment.
Results:
A greater proportion of intervention group reached the LDL-C <70 mg/ml [55.0% vs 12.5%, p = 0.003; OR: 3.26 IC (1.16-9.15)]. "High potency statins" and combined therapy were used more frequently in the intervention group than the control group (p = 0.001). Seven adverse effects were documented in the intervention group and two in the control group. An acceptable relationship was observed with regard to costeffectiveness in the intervention group. Physicians expressed good agreement with HTE-DLP (86.1%) and comfortable ease-of-use (85%).
Conclusions:
Use of a CDSS in high-risk cardiovascular patients resulted in a significant reduction in LDL-C levels.
Related Concept Videos
01:26Atherosclerosis III: Management
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Coronary Artery Disease IV: Preventive Measures